Bluebird Bio's market cap is currently $68.44M. The company's EPS TTM is $-35.974; its P/E ratio is ―; Bluebird Bio is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-5.78. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 29.50M	$ 3.60M	$ 3.66M	$ 250.73M	$ 44.67M
Gross Profit	$ -4.03M	$ -6.48M	$ -35.20M	$ 245.34M	$ 41.70M
Operating Income	$ -244.26M	$ -287.09M	$ -590.91M	$ -629.51M	$ -812.08M
EBITDA	$ -167.16M	$ -215.56M	$ -556.93M	$ -553.63M	$ -772.72M
Net Income	$ -211.91M	$ -266.58M	$ -562.64M	$ -618.70M	$ -789.61M
Balance Sheet
Cash & Short-Term Investments	$ 221.75M	$ 181.74M	$ 396.62M	$ 1.27B	$ 1.24B
Total Assets	$ 619.16M	$ 554.90M	$ 593.79M	$ 1.78B	$ 1.73B
Total Debt	$ 330.33M	$ 281.39M	$ 89.58M	$ 193.02M	$ 190.99M
Net Debt	$ 108.57M	$ 168.38M	$ -71.58M	$ -124.68M	$ -136.23M
Total Liabilities	$ 424.62M	$ 358.56M	$ 219.52M	$ 426.20M	$ 442.43M
Stockholders' Equity	$ 194.54M	$ 196.34M	$ 374.28M	$ 1.36B	$ 1.28B
Cash Flow
Free Cash Flow	$ -244.10M	$ -366.16M	$ -658.64M	$ -499.34M	$ -640.64M
Operating Cash Flow	$ -235.05M	$ -352.95M	$ -635.64M	$ -470.35M	$ -564.38M
Investing Cash Flow	$ 154.95M	$ 250.45M	$ 562.56M	$ -84.34M	$ 507.81M
Financing Cash Flow	$ 196.25M	$ 54.25M	$ -93.95M	$ 546.72M	$ 21.19M

Currency in USD

Bluebird Bio Earnings and Revenue History

Income Statement >

Bluebird Bio Debt to Assets

Balance Sheet >

Bluebird Bio Cash Flow

Cash Flow >

Bluebird Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing